{
  "id": "0fc858ddfd37ef65",
  "title": "STAT+: ImmunityBio\u2019s Soon-Shiong mischaracterized talks with FDA over cancer drug, sources say",
  "description": "ImmunityBio Chairman Patrick Soon-Shiong mischaracterized talks with the FDA over the company's cancer drug, sources say.",
  "content": "ImmunityBio Chairman Patrick Soon-Shiong mischaracterized talks with the FDA over the company's cancer drug, sources say.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/29/immunitybio-soon-shiong-anktiva-bladder-cancer/?utm_campaign=rss",
  "published_at": "2026-01-29T11:30:00+00:00",
  "fetched_at": "2026-01-30T00:27:47.504790+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "drug",
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: ImmunityBio\u2019s Soon-Shiong mischaracterized talks with FDA over cancer drug, sources say",
    "description": "ImmunityBio Chairman Patrick Soon-Shiong mischaracterized talks with the FDA over the company's cancer drug, sources say.",
    "url": "https://www.statnews.com/2026/01/29/immunitybio-soon-shiong-anktiva-bladder-cancer/?utm_campaign=rss",
    "published": "2026-01-29T11:30:00+00:00",
    "source": "STAT"
  }
}